1.

Teklemichael AA, Teshima A, Hirata A, Akimoto M, Taniguchi M, Khodakaramian G, Fujimura T, Tokumasu F, Arakawa K, Mizukami S.Discovery of antimalarial drugs from secondary metabolites in actinomycetes culture library. Trop Med Health. 52(1):47, 2024.

2.

Nakamae S, Miyagawa S,Ogawa K, Kamiya M, Taniguchi M, Ono A, Kawaguchi M, Teklemichael AA, Jian JY, Araki T, Katagami Y, Mukai H, Annoura T, Yui K, Hirayama K, Kawakami S, Mizukami S.Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles. Front Immunol. 14:1116299, 2023.

3.

Tayama Y, Mizukami S, Toume K, Komatsu K, Yanagi T, Nara T, Tieu P, Huy NT, Hamano S, Hirayama K. Anti-Trypanosoma cruzi activity of Coptis rhizome extract and its constituents. Trop Med Health. 1;51(1):12, 2023.

4.

Mizuta S, Mosaddeque F, Tun MMN, Teklemichael AA, Taniguchi M, Hosokawa M, Yamaguchi T, Makau J, Huy NT, Mizukami S, Nishida N, Morita K, Hirayama K. Challenges Based on Antiplasmodial and Antiviral Activities of 7-Chloro-4-aminoquinoline Derivatives. ChemMedChem. 3;18(7):e202200586, 2023.

5.

Kawaguchi M, Noda M, Ono A, Kamiya M, Matsumoto M, Tsurumaru M, Mizukami S, Mukai H, Kawakami S. Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice. J Pharm Sci. 112(5):1401-1410, 2023.

6.

Mizoguchi I, Katahira Y, Inoue S, Sakamoto E, Watanabe A, Furusaka Y, Irie A, Senju S, Nishimura Y, Mizukami S, Hirayama K, Nakamura S, Eto K, Hasegawa H, Yoshimoto T. A novel coculture system for assessing respiratory sensitizing potential by IL-4 in T cells. ALTEX.40(2):204-216, 2023.

7.

Kamiya M, Matsumoto M, Yamashita K, Izumi T, Kawaguchi M, Mizukami S, Tsurumaru M, Mukai H, Kawakami S. Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability. Pharmaceutics.14(11):2357, 2022.

8.

Ogawa K, Kato N, Yoshida M, Hiu T, Matsuo T,Mizukami S, Omata D, Suzuki R, Maruyama K, Mukai H, Kawakami S. Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain. J Control Release.348:34-41, 2022.

9.

Ngwe Tun MM, Luvai E, Nwe KM, Toume K, Mizukami S, Hirayama K, Komatsu K, Morita K.　Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro. Arch Virol,167(7):1547-1557, 2022.

10.

Ngwe Tun MM, Toume K, Luvai E, Nwe KM, Ogawa K, Kamiya M, Mizukami S, Hirayama K, Komatsu K, Morita K. The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro. J Nat Med.76(2):402-409, 2022.

11.

Nakamae S, Miyagawa S, Ogawa K, Kamiya M, Taniguchi M, Ono A, Kawaguchi M, Teklemichael AA, Jian JY, Araki T, Katagami Y, Mukai H, Annoura T, Yui K, Hirayama K, Kawakami S, Mizukami S. Phenylpropanoid-conjugated iridoid glucosides from leaves of Morindamorindoides. J Nat Med 2021.

12.

Hashim Y, Toume K, Mizukami S, Kitami T, Taniguchi M, Teklemichael AA, Tayama Y, Huy NT, Lami JN, Bodi JM, Hirayama K, Komatsu K. Phenylpropanoid-conjugated iridoid glucosides from leaves of Morindamorindoides.J Nat Med, 2021.

13.

Hashim Y, Toume K, Mizukami S, Ge YW, Taniguchi M, Teklemichael AA, Huy NT, Bodi JM, Hirayama K, Komatsu K. Phenylpropanoid conjugated iridoids with anti-malarial activity from the leaves of Morindamorindoides.J Nat Med, 75(4):915-925, 2021.

14.

Raini SK, Takamatsu Y, Dumre SP, Urata S, Mizukami S, Moi ML, Hayasaka D, Inoue S, Morita K, Ngwe Tun MM. The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.Antiviral Res, 192:105121, 2021.

15.

Nguyen PTV, Van Dat T, Mizukami S, Nguyen DLH, Mosaddeque F, Kim SN, Nguyen DHB, Đinh OT, Vo TL, Nguyen GLT, Quoc Duong C, Mizuta S, Tam DNH, Truong MP, Huy NT, Hirayama K. 2D-quantitative structure-activity relationships model using PLS method for anti-malarial activities of anti-haemozoin compounds.Malar J, 20(1):264, 2021.

16.

Tran L, Radwan I, Minh LHN, Low SK, Hashan MR, Gomaa MD, Abdelmongy M, Abdelaziz AI, Mohamed A, Tawfik GM, Mizukami S, Hirayama K, Huy NT. Role of cytokines produced by T helper immune-modulators in dengue pathogenesis: A systematic review and meta-analysis.Acta Trop, 216:105823, 2021.

17.

Manh DH, Weiss LN, Thuong NV, Mizukami S, Dumre SP, Luong QC, Thanh LC, Thang CM, Huu PT, Phuc LH, Nhung CTH, Mai NT, Truong NQ, Ngu VTT, Quoc DK, Ha TTN, Ton T, An TV, Halhouli O, Quynh LN, Kamel MG, Karbwang J, Huong VTQ, Huy NT, Hirayama K. Kinetics of CD4+ T Helper and CD8+ Effector T Cell Responses in Acute Dengue Patients.Front Immunol, 11:1980, 2020.

18.

Pembi E, John S, Dumre SP, Ahmadu BU, Vuong NL, Ebied A, Mizukami S, Huy NT, Cuevas LE, Hirayama K. Impact of political conflict on tuberculosis notifications in North-east Nigeria, Adamawa State: a 7-year retrospective analysis.BMJ Open, 10(9):e035263, 2020.

19.

Iglesias Rodríguez IM, Mizukami S, Manh DH, Thuan TM, Justiniano HA, Miura S, Ito G, Huy NT, Smith C, Hirayama K.Knowledge, behaviour and attitudes towards Chagas disease among the Bolivian migrant population living in Japan: a cross-sectional study. BMJ Open, 10(9):e032546, 2020.

20.

Teklemichael AA, Mizukami S, Toume K, Mosaddeque F, Kamel MG, Kaneko O, Komatsu K, Karbwang J, Huy NT, Hirayama K.Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds. Malar J, 19(1):204, 2020.

21.

Vásquez Velásquez C, Russomando G, Espínola EE, Sanchez Z, Mochizuki K, Roca Y, Revollo J, Guzman A, Quiroga B, Rios Morgan S, Vargas Ortiz R, Zambrana Ortega A, Espinoza E, Nishizawa JE, Kamel MG, Kikuchi M, Mizukami S, Na-Bangchang K, Tien Huy N, Hirayama K.IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia. PLoSNegl Trop Dis, 13(9):e0007715, 2019.